The Impact of PDE5 Inhibitors on Major Adverse Cardiac Events (MACE)

For the latest updates on urology, men's health, and uro-oncology, join our community: https://grandroundsinurology.com/join... E. David Crawford, MD, sits down with Robert A. Kloner, MD, PhD, and Raymond Rosen, MD, to discuss retrospective evidence of PDE5 inhibitors in preventing major adverse cardiac events (MACE) in men. Crawford, Kloner, and Rosen discuss a retrospective study examining occurrences of MACE in men which demonstrated a significant reduction in MACE in men using PDE5 inhibitors versus those who were not.